Shares
 | 
Bonds
 | 
Funds
 | 
Compensations
 | 
Options
 
 
30 July 2010 13:37 3.860 0.065 (1.71%)

Sopharma AD (3JR / SFARM)

 
Quotes
 | 
Graphics
 | 
Price Stats
 | 
Consensus
 | 
News
 | 
Disclosure
 | 
Statements
 | 
Ratios
 | 
Profile
 | 
Insider trading
 | 
Forum
 
 

DetailsProfitability Ratios

  Company Sector
ROE 14.01% 9.06%
ROFA 15.39% 8.78%
ROA 8.82% 5.03%
ROCE 11.39% 7.96%
Operating Margin 18.59% 7.02%
Pretax Margin 18.59% 7.02%
Net Profit Margin 16.39% 6.30%
CFO/Sales 18.63 12.12
CFO/Equity 15.92 14.01
CFO/Total Liabilities 27.04 36.77
Sales/Employees 107K -
Net Income/Employees 18K -
FCF 33 208K 4 281K
EBIT 45 350K 9 359K
EBITDA 53 741K 13 410K
Dividend Cover 5.08 -
Dividend Payout 0.20 -
Retained Earnings 0.80 -

DetailsLiquidityAndAsset

  Company Sector
Quick Ratio 1.02 1.56
Current Ratio 1.35 2.40
TA/Employees 218K 201K
Cashflow Interest 5.23 6.38
Interest Cover 7.54 8.57
Assets Turnover 0.54 0.78
Fixed Assets Turnover 0.94 1.42
Inventory Turnover 4.46 5.96
Receivables Turnover 1.93 6.36
Working Capital Turnover 4.87 2.75
Altman Z-Score 3.00 -
Market Liquidity 7.43% 8.93%

DetailsPerShare Ratios

  Company Sector
Dividends Per Share 0.05 0.23
BVPS 2.11 5.11
Earnings Per Share 0.28 0.54
EBITDA Per Share 0.41 1.11
Sales Per Share 1.69 7.28
FCF Per Share 0.25 0.49

DetailsGearing Ratios

  Company Sector
TA/Equity 1.57 1.85
Long Term Debt/Equity 0.04 0.18
Long Term Debt/TA 0.03 0.08
Total Debt/Equity 0.57 0.84
Total Debt/TA 0.36 0.39

DetailsGrouth Ratios

  Company Sector
Total Assets Growth 11.14% 8.75%
BVPS Growth 17.23% 23.87%
Sales Growth 22.89% 1.43%
CFO Growth 49.40% 48.09%
FCF Growth 62.60% 139.33%
EBIT Growth -4.69% 54.37%
Net Income Growth -1.52% 633.05%
EPS Growth -1.52% 633.05%
Dividend Growth - 0.00%
Price Growth 36.98% 28.79%

DetailsMarket Ratios

 
  Company Sector
P/E 13.92 18.25
P/E 52W High 19.32 -
P/E 52W Low 11.35 -
P/E vs Index 0.86 -
P/E vs Sector 0.76 -
Yield 7.18% 10.42%
Dividend Yield 1.30% 4.61%
Dividend Yield vs Index 0.12 -
Dividend Yield vs Sector 0.28 -
P/B 1.83 1.12
P/S 2.28 0.76
P/CF 9.48 5.76
P/FCF 15.34 17.36
Enterprise Value (EV) 652 139K 153 954K
EV/EBITDA 12.13 9.51
EV/Sales 2.92 1.20
Ratio calculations on this page is based on non consolidated data and include the last published statement from the company, unless other is selected.
Last published non consolidated statment from: 6/2010